Patents by Inventor Shay Asis

Shay Asis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8592442
    Abstract: Crystalline forms of Nilotinib HCl are described.
    Type: Grant
    Filed: June 27, 2012
    Date of Patent: November 26, 2013
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Greta Sterimbaum, Sigalit Levi, Adi Yeori, Tamas Koltai, Valerie Niddam-Hildesheim, Maytal Piran, Shay Asis, Hagit Eisen-Nevo, David Malcolm Crowe
  • Publication number: 20130096304
    Abstract: Crystalline forms of Nilotinib HCl are described.
    Type: Application
    Filed: June 27, 2012
    Publication date: April 18, 2013
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Greta Sterimbaum, Sigalit Levi, Adi Yeori, Tamas Koltai, Valerie Niddam-Hildesheim, Maytal Piran, Shay Asis, Hagit Eisen-Nevo, David Malcolm Crowe
  • Patent number: 8227477
    Abstract: Crystalline forms of Nilotinib HCl are described.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: July 24, 2012
    Inventors: Greta Sterimbaum, Sigalit Levi, Adi Yeori, Tamas Koltai, Valerie Niddam-Hildesheim, Maytal Piran, Shay Asis, Hagit Eisen-Nevo, David Malcolm Crowe
  • Publication number: 20100041885
    Abstract: A Sitagliptin phosphate characterized by data selected from the group consisting of: a powder XRD pattern with peaks at 4.7, 13.5, 17.7, 18.3, and 23.7±0.2 degrees two theta; a powder XRD pattern with peaks at about 4.7, 13.5, and 15.5±0.2 degrees two theta and at least another two peaks selected from the following list: 14.0, 14.4, 18.3, 19.2, 19.5 and 23.7±0.2 degrees two theta; and a powder XRD pattern with peaks at about 13.5, 19.2, and 19.5±0.2 degrees two theta and at least another two peaks selected from the following list: 4.7, 14.0, 15.1, 15.5, 18.3, and 18.7±0.2 degrees two theta; a powder XRD pattern with peaks at about 13.5, 15.5, 19.2, 23.7, and 24.4±0.2 degrees two theta; and a powder XRD pattern with peaks at about 4.65, 13.46, 17.63, 18.30, and 23.66±0.10 degrees two theta, processes for preparing said Sitagliptin crystalline form, and pharmaceutical compositions thereof, are provided.
    Type: Application
    Filed: March 25, 2009
    Publication date: February 18, 2010
    Inventors: Nurit Perlman, Revital Ramaty, Mili Abramov, Nina Finkelstein, Eli Lancry, Shay Asis, Ariel Mittelman